These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6178151)

  • 1. [1st direct comparison of allergic side effects of dextran with and without hapten].
    Gruber UF; Allemann U; Wettler H
    Schweiz Med Wochenschr; 1982 Apr; 112(17):605-12. PubMed ID: 6178151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antithrombotic efficacy of dextran.
    Ljungström KG
    Acta Chir Scand Suppl; 1988; 543():26-30. PubMed ID: 2461016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Severe dextran-induced anaphylactic/anaphylactoid reaction despite preventive hapten administration].
    Allhoff T; Lenhart FP
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):301-6. PubMed ID: 7511449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. II. A comparison of the effects of 20 ml dextran 1, 15%, administered either admixed to or before dextran 70 or dextran 40.
    Renck H; Ljungström KG; Rosberg B; Dhunér KG; Dahl S
    Acta Chir Scand; 1983; 149(4):349-53. PubMed ID: 6193666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis of postoperative thromboembolism with dextran 70: improvements of efficacy and safety.
    Ljungström KG
    Acta Chir Scand Suppl; 1983; 514():1-40. PubMed ID: 6193669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylactoid reactions to Dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004.
    Zinderman CE; Landow L; Wise RP
    J Vasc Surg; 2006 May; 43(5):1004-9. PubMed ID: 16678697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A severe reaction to dextran despite hapten inhibition.
    Bernstein RL; Rosenberg AD; Pada EY; Jaffe FF
    Anesthesiology; 1987 Oct; 67(4):567-9. PubMed ID: 2444140
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. I. A Scandinavian multicenter study on the effects of 10 ml dextran 1, 15% administered before dextran 70 or dextran 40.
    Ljungström KG; Renck H; Hedin H; Richter W; Rosberg B
    Acta Chir Scand; 1983; 149(4):341-8. PubMed ID: 6193665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serious complications with dextran-70 despite hapten prophylaxis. Is it best avoided prior to delivery?
    Berg EM; Fasting S; Sellevold OF
    Anaesthesia; 1991 Dec; 46(12):1033-5. PubMed ID: 1723580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing surveillance of dextran 1.
    Ljungström KG; Willman B; Hedin H
    Ann Fr Anesth Reanim; 1993; 12(2):219-22. PubMed ID: 7690207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hapten inhibition: inhibition of antibody dependent dextran side effects by means of low molecular dextran (dextran 1) as a monovalent hapten].
    Schwarz JA
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):105-8. PubMed ID: 6159322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of postoperative thromboembolism by dextran 70 or low-dose heparin.
    Hohl MK; Lüscher KP; Tichý J; Stiner M; Fridrich R; Gruber UF; Käser O
    Obstet Gynecol; 1980 Apr; 55(4):497-500. PubMed ID: 6154272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of dextran-induced anaphylactic reactions by hapten inhibition. III. A Scandinavian multicenter study on the effects of 20 ml dextran 1, 15%, administered before dextran 70 or dextran 40.
    Renck H; Ljungström KG; Hedin H; Richter W
    Acta Chir Scand; 1983; 149(4):355-60. PubMed ID: 6193667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of dextran-induced anaphylactoid reactions by preinjection of 20 ml hapten in 12 000 patients in Switzerland].
    Gruber UF; Wettler H; Allemann U; Gerber H; Laubenthal H; Messmer K
    Schweiz Rundsch Med Prax; 1982 Jun; 71(26):1092-100. PubMed ID: 6181497
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of dextran-induced anaphylactoid reactions by hapten inhibition.
    Edwards AM; Holland A
    Lancet; 1980 Jun; 1(8181):1307. PubMed ID: 6155580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of thromboembolism with dextran].
    Gruber UF; Guardiola PM
    Agressologie; 1983 Dec; 24(12):617-20. PubMed ID: 6199996
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dextran for the prophylaxis of postoperative thromboembolism (author's transl)].
    Rahmer H
    Langenbecks Arch Chir; 1977 Nov; 345():365-9. PubMed ID: 592990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of dextran in relation to other colloids--ten years experience with hapten inhibition.
    Ljungström KG
    Infusionsther Transfusionsmed; 1993 Oct; 20(5):206-10. PubMed ID: 7508309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, pathomechanism and prevention of dextran-induced anaphylactoid / anaphylactic reactions in man.
    Hedin H; Richter W; Messmer K; Renck H; Ljungström KG; Laubenthal H
    Dev Biol Stand; 1980; 48():179-89. PubMed ID: 6168503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hapten inhibition and dextran anaphylaxis.
    Ljungström KG; Renck H; Hedin H; Richter W; Wiholm BE
    Anaesthesia; 1988 Sep; 43(9):729-32. PubMed ID: 2459986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.